ALL, ADULT

Clinical trials for ALL, ADULT explained in plain language.

Never miss a new study

Get alerted when new ALL, ADULT trials appear

Sign up with your email to follow new studies for ALL, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug trial aims to wipe out lingering leukemia cells after chemo

Disease control Not yet recruiting

This study is testing an existing drug, daratumumab, for adults with a hard-to-treat type of leukemia called T-ALL. It's for patients who have responded to standard chemotherapy but still have tiny amounts of cancer cells left, which raises the risk of the disease coming back. Th…

Matched conditions: ALL, ADULT

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 03, 2026 14:06 UTC

ALL, ADULT

Get alerted when new ALL, ADULT trials appear

New drug trial aims to wipe out lingering leukemia cells after chemo